CLINICAL_TRIALS trial_result · 2017-11-17

Clinical Trial Update: A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder [Phase 2]

Phase 2 study evaluating the effects of the antidepressant GSK561679 in females with major depressive disorder; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder, Major | Phase 2 | Status: COMPLETED | Results posted: 2017-11-17